DocGo (DCGO) Soars 7.9%: Is Further Upside Left in the Stock?

DocGo Inc. DCGO shares ended the last trading session 7.9% higher at $5.44. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 23.5% gain over the past four weeks.DocGo Inc. recorded a strong price rise on investors’ optimism surrounding the company’s latest acquisition of PTI Health, a mobile lab collection and phlebotomy services company. With this acquisition, DocGo will facilitate timely, convenient blood collection and additional at-home testing services for patients. This company is expected to post quarterly earnings of $0.04 per share in its upcoming report, which represents a year-over-year change of -33.3%. Revenues are expected to be $128.57 million, down 35.5% from the year-ago quarter.Earnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements.For DocGo, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on DCGO going forward to see if this recent jump can turn into more strength down the road.The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>DocGo belongs to the Zacks Medical Services industry. Another stock from the same industry, Establishment Labs Holdings Inc. ESTA, closed the last trading session 5.8% higher at $30.15. Over the past month, ESTA has returned -37.7%.Establishment Labs' consensus EPS estimate for the upcoming report has remained unchanged over the past month at -$0.62. Compared to the company's year-ago EPS, this represents a change of +21.5%. Establishment Labs currently boasts a Zacks Rank of #4 (Sell).Only $1 to See All Zacks' Buys and SellsWe're not kidding.Several years ago, we shocked our members by offering them 30-day access to all our picks for the total sum of only $1. No obligation to spend another cent.Thousands have taken advantage of this opportunity. Thousands did not - they thought there must be a catch. Yes, we do have a reason. We want you to get acquainted with our portfolio services like Surprise Trader, Stocks Under $10, Technology Innovators,and more, that closed 256 positions with double- and triple-digit gains in 2024 alone.See Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report DocGo Inc. (DCGO): Free Stock Analysis Report Establishment Labs Holdings Inc. (ESTA): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks